Le Lézard
Classified in: Health
Subject: NEW PRODUCTS/SERVICES

Entourage Health Introduces New Product Launches and Expands Market Reach of Leading Brand Dime Bag®


TORONTO, May 08, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), an established Canadian producer and distributor of award-winning cannabis products, today unveiled the expansion of its product portfolio.

Entourage also announced the expansion of Dime Bag-branded pre-rolls into Alberta, introducing Diesel and Tropical Pocket Puffs. A package of four pre-rolls, each containing 0.5g, is available for a suggested retail price of $10.00 inclusive of taxes. This strategic move leverages Dime Bag's significant momentum in Ontario. Recent data highlights the brand's rapid growth, positioning Dime Bag as the third fastest-growing pre-roll product in the province for the last two consecutive quarters.1 Entourage anticipates the spring launch will mirror the brand's popularity throughout Alberta.

"At Entourage, we are dedicated to providing what consumers truly want ? variety, quality, and a premium experience, guided by comprehensive market research and valuable consumer feedback," shared Joseph Mele, Chief Commercial Officer. "Our offerings are not just products; they reflect evolving consumer trends and respond to the dynamic demands of the market, consistently elevating our brand appeal with each release."

Spring Brings Fresh Offerings from Color Cannabis

Additionally, Color has extended its whole flower range, featuring 'Jazzberry' in 3.5g, 'Mango Haze' in 3.5g, 7g and 15g, 'Pedro's Sweet Sativa' in 3.5g, 7g and 15g, and the full-bodied 'Phantom Sunset' in 3.5g and 7g. These varieties are available at authorized cannabis retailers across select Canadian regions.

Saturday Cannabis Unveils New Vape Products

Saturday Cannabis launches new 'Sour Blueberry' 1g vape a fusion of smooth, tangy berry flavours with a citrusy twist, now available across Ontario. Expanding its vape portfolio, Saturday introduces a vibrant summer collection featuring 'Raspberry Ice,' 'Watermelon,' and 'Beached Mango' offering consumers a refreshing and diverse vaping experience, now available nationwide.

Company Update

On April 30, 2024, the Company announced that it was in breach of certain financial covenants and other obligations under each of its Senior Credit Agreement and Subordinated Credit Agreement with an affiliate of the LiUNA Pension Fund of Central and Eastern Canada ("LPF") and was working collaboratively with LPF to reach an agreement on refined debt terms. Consequently, the Company received a renewed forbearance letter on May 3, 2024, waiving the Company's breaches until August 2, 2024, subject to the satisfaction or waiver of certain conditions.

About Entourage Health Corp. 

Entourage Health Corp. is the publicly traded parent Company of Entourage Brands Corp., a licence holder producing and distributing cannabis products for the medical and adult-use markets. The Company owns and operates a fully licensed 26,000 sq. ft. Aylmer, ON processing facility. With its Starseed Medicinal medical-centric brand, Entourage has expanded its multi-channelled distribution strategy. Starseed's industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with employers and union groups, complements Entourage's direct sales to medical patients. Entourage's elite adult-use product portfolio includes Color Cannabis, Saturday Cannabis ? and now Dime Bag and Syndicate ? sold across eight provincial distribution agencies. Exclusive Canadian producer and distributor of award-winning U.S.-based wellness brand Mary's Medicinals, sold in both medical and adult-use channels in addition, Entourage also entered into an exclusive agreement with Irwin Naturals, nutraceutical and herbal supplement formulator of popular branded wellness products sold across North America. 

Follow Entourage and its brands on LinkedIn 
Instagram: Color Cannabis, Saturday Cannabis, Starseed, Syndicate, Dime Bag

For Investor & Media Enquiries:
Catherine Flaman
Senior Director, Communications & Corporate Affairs
416-910-0279
[email protected]

Forward Looking Information This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation which are based upon Entourage's current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward looking information can be identified using forward-looking terminology such as "expect," "likely," "may," "will," "should," "intend," "anticipate," "potential," "proposed," "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may," "would" or "will" happen, or by discussions of strategy.

The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions, and views of future events which management believes to be reasonable in the circumstances. Forward looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance, or other statements that are not statements of fact. Forward looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of Entourage to implement its business strategies; competition; crop failure; and other risks.

Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, Entourage does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for Entourage to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in Entourage's disclosure documents filed with the applicable Canadian securities regulatory authorities and available on SEDAR+ at www.sedarplus.ca. The risk factors and other factors noted in the disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

_________________________

1 Hifyre data on pre-roll sales encompasses the three-month period ending December 31, 2023, as well as the subsequent quarter concluding on March 31, 2024. 



These press releases may also interest you

at 18:00
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 12:18
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...



News published on and distributed by: